Arnold E P, Bailey C, Burry A F, Bydder P V, Firth L A, Gowland S, Gray A J, Mcllroy R
N Z Med J. 1981 Apr 22;93(682):273-5.
A new anti-cancer agent, misonidazole, is now available for investigational purposes. It is a radiation sensitiser, and a national trial is described for its use in the curative treatment of carcinoma of the bladder. The co-operation of doctors is sought in referring patients for this study.
一种新型抗癌药米索硝唑现已可供用于研究目的。它是一种放射增敏剂，本文描述了一项关于其用于膀胱癌根治性治疗的全国性试验。现寻求医生们的合作，以便将患者转介至该研究。
